Showing results (41-50 of 2,435) with videos related to

Sort By:
Pageof 244
Diabetic Medicine : a Journal of the British Diabetic Association|February 24, 1998
Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathyN Koppiker, J Feehally, N Raymond, et al.
Renal Failure|January 1, 1987
Recurrent acute renal failure with interstitial nephritis due to D-penicillamineJ Feehally, D C Wheeler, E H Mackay, et al.
Clinical and Experimental Immunology|June 1, 1992
Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathyL Layward, A C Allen, S J Harper, et al.
Experimental Nephrology|September 1, 1995
Response to mucosal antigen challenge in IgA nephropathyL Layward, A C Allen, J M Hattersley, et al.
Clinical Immunology and Immunopathology|December 1, 1993
Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathyL Layward, A M Finnemore, A C Allen, et al.
Clinical and Experimental Immunology|January 1, 1994
Low antibody affinity restricted to the IgA isotype in IgA nephropathyL Layward, A C Allen, J M Hattersley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclassL Layward, A C Allen, J M Hattersley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1997
Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrierC Lasseur, A C Allen, C Deminière, et al.
Journal of the American Society of Nephrology : JASN|August 14, 1999
Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresisA C Allen, E M Bailey, J Barratt, et al.
Journal of Internal Medicine|December 1, 1992
Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversibleM A Devoy, C R Tomson, M E Edmunds, et al.
Pageof 244